Tyme Technologies NASDAQ:TYME Tyme Technologies, Inc., is an emerging biotechnology company developing cancer therapeutics that are intended to be broadly effective across tumor types and have low toxicity profiles. Unlike targeted therapies that attempt to regulate specific mutations within cancer, the Company's therapeutic approach is designed to take advantage of a cancer cell's innate metabolic weaknesses to compromise its defenses, leading to cell death through oxidative stress and exposure to the body's natural immune system. With the development of TYME-18 and TYME-19, the Company believes that it is also emerging as a leader in the development of bile acids as potential therapies for cancer and COVID-19.

Location: 1 Pluckemin Way - Suite 103, New Jersey, 07921, United States | Website: www.tymeinc.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing